Cancer Incidence and Mortality in Familial Adenomatous Polyposis Syndrome
Daniel C. Chung(Massachusetts General Hospital), Matthew B. Yurgelun(Dana-Farber Cancer Institute), Linda Rodgers(Massachusetts General Hospital), Sapna Syngal(Brigham and Women's Hospital), Chinedu Ukaegbu(Dana-Farber Cancer Institute)
Cited by 1
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k